| Stage | LRCX | % of rev | CRCT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $8.2B | 100.00% | $189M | 100.00% | LRCX ×43.58 |
| Gross profit | $4.3B | 52.30% | $109M | 57.72% | CRCT +5.4pp |
| Operating income | $3.3B | 39.95% | $34M | 17.97% | LRCX +22.0pp |
| Pre-tax income | $3.3B | 40.30% | $36M | 19.28% | LRCX +21.0pp |
| Net income | $2.8B | 33.50% | $28M | 14.76% | LRCX +18.7pp |
| Stage | LRCX | CRCT | Gap · A − B |
|---|---|---|---|
| Revenue | $8.2B100.00% | $189M100.00% | LRCX ×43.58 |
| Gross profit | 52.30%$4.3B | 57.72%$109M | CRCT +5.4pp |
| Operating income | 39.95%$3.3B | 17.97%$34M | LRCX +22.0pp |
| Pre-tax income | 40.30%$3.3B | 19.28%$36M | LRCX +21.0pp |
| Net income |
| 33.50%$2.8B |
| 14.76%$28M |
| LRCX +18.7pp |
No shared counterparties.